Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT00025168
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed locally advanced pancreatic cancer
* Regional (peri-pancreatic) lymph node involvement allowed
* Clinically or surgically staged and considered unresectable or inoperable
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* ECOG 0-2
Life expectancy:
* More than 6 months
Hematopoietic:
* Granulocyte count at least 1,500/mm3
* Hemoglobin at least 10 g/dL
* Platelet count at least 100,000/mm3
Hepatic:
* Not specified
Renal:
* Creatinine no greater than 2.0 mg/dL
Other:
* Not pregnant
* Fertile patients must use effective contraception
* No other concurrent or prior malignancy within the past 2 years except nonmelanoma skin cancer or in situ carcinoma of the cervix or breast
* No other serious medical or psychiatric illness that would preclude giving informed consent or limit survival to less than 2 years
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* No concurrent anticancer immunotherapy
Chemotherapy:
* No prior chemotherapy
* No other concurrent anticancer chemotherapy
Endocrine therapy:
* No concurrent anticancer hormonal therapy
Radiotherapy:
* No prior abdominal-pelvic radiotherapy
* No other concurrent anticancer radiotherapy
Surgery:
* See Disease Characteristics
* At least 3 weeks since prior open abdominal surgery
* More than 10 days since prior laparoscopy
Other:
* No other concurrent investigational drug
* No concurrent participation in other clinical study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00025168
Study Brief:
Protocol Section:
NCT00025168